Rat's Rant: What's hot, what's not and... the Bali anniversary
Oct 2, 2019
Oct 2, 2019 |
10 min
Actinogen closed up 466% to finish at 5.1c on $15.8 million stock traded. The company announced results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial. The results demonstrate a significant improvement in cognition in trial participants dosed with Xanamem 20mg daily for 12 weeks, compared to placebo.
Rat's Rant: Stocks that are hot, not and... Constable Chapman
Sep 10, 2019
Sep 10, 2019 |
17 min
EVS has signed a legally binding agreement to secure a strategically funded entry into the China market that the Board sees as potentially transnational to company value.
Contract success drives Envirosuite to new levels
Mar 7, 2019
Mar 7, 2019 |
4 min
Envirosuite Limited (ASX:EVS) appears ready for a strong run on the back of multiple contract success with recent share price momentum.
